Wire Stories
670ASC20-21 Student Supercomputer Challenge: Search for Pulsars and Inspire the Universe Exploration
BEIJING, China–(BUSINESS WIRE)–The preliminary round of the 2020-2021 ASC Student Supercomputer Challenge (ASC20-21) has kicked off. In two months, participating teams from...
- 747
Blue Yonder Named a Great Place to Work®
Company now recognized as a Great Place to Work Certified™ in the U.S. and India for 2020-2021, adding to its employer-based recognitions...
- 723
Arista Unveils Attack Surface Assessment Service
Delivers AI-driven advanced threat hunting and incident response expertise SANTA CLARA, Calif.–(BUSINESS WIRE)–Arista Networks (NYSE:ANET) today announced an Attack Surface Assessment, an...
- 833
HitGen Announces License Agreement With Merck & Co., Inc., Kenilworth, NJ USA to Access Compounds for Potential Development of a Novel Class of Drugs
CHENGDU, China–(BUSINESS WIRE)–HitGen Inc. is pleased to announce that HitGen and Merck & Co., Inc., Kenilworth, NJ USA, known as MSD outside...
- 823
Propanc Biopharma Receives First Granted Patent for Method to Treat Cancer Stem Cells from Australian Patent Office
MELBOURNE, Australia–(BUSINESS WIRE)–Propanc Biopharma, Inc. (OTC: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from...
- 885
First Patients, Including a COVID-19 Patient, Treated with Abiomed’s Innovative ECMO Technology
DANVERS, Mass.–(BUSINESS WIRE)–Abiomed (NASDAQ: ABMD) announces the first two patients in the world have been treated with the Abiomed Breethe OXY-1 System,...
- 698
Middleby Acquires United Foodservice
ELGIN, Ill.–(BUSINESS WIRE)–The Middleby Corporation (NASDAQ: MIDD) today announced the acquisition of Zhuhai Guangdong China-based United Foodservice Equipment Group. The company is...
- 733
Azura Ophthalmics Announces Primary Endpoints Met in Topline Results from Phase 2 Trial of the Company’s Investigational Treatment for Contact Lens Discomfort
Significant improvement in multiple measures of Meibomian gland secretion and associated improvements in contact lens wear time TEL AVIV, Israel & MELBOURNE,...
- 794
Regenacy Announces the Formation of a Joint Venture with 3E Bioventures to Develop Ricolinostat in China and the Start of a U.S. Phase 2 Study in Painful Diabetic Peripheral Neuropathy
WALTHAM, Mass.–(BUSINESS WIRE)–Regenacy Pharmaceuticals, a clinical-stage biopharmaceutical company developing breakthrough treatments for diabetic and other peripheral neuropathies, and 3E Bioventures Capital, a...
- 722
Legend Biotech Announces Initiation of Rolling Submission of Biologics License Application to U.S. FDA Seeking Approval of BCMA CAR-T Therapy Cilta-cel for the Treatment of Relapsed and/or Refractory Multiple Myeloma
Legend Biotech also achieves fifth milestone payment under its collaboration agreement with Janssen in clinical development of cilta-cel SOMERSET, N.J.–(BUSINESS WIRE)–#LegendBiotech–Legend Biotech...
